Interleukin-6 Levels in Behcet's Disease
Author Information
Author(s): K. Hamzaoui, A. Hamzaoui, A. Kahan, M. Hamza, A. Chabbou, Kh. Ayed
Primary Institution: Faculté de Médecine de Tunis, Tunisia
Hypothesis
IL-6 levels are elevated in patients with Behcet's disease compared to healthy controls and rheumatoid arthritis patients.
Conclusion
The study found that active Behcet's disease patients have significantly higher IL-6 levels in serum and synovial fluid compared to healthy controls and inactive patients.
Supporting Evidence
- IL-6 levels in active Behcet's disease patients were significantly higher than in healthy controls.
- IL-6 production by PBMC was significantly increased in active Behcet's disease patients compared to inactive patients.
- IL-6 levels in synovial fluid were similar in active Behcet's disease and rheumatoid arthritis patients.
Takeaway
This study shows that people with active Behcet's disease have more of a substance called IL-6 in their blood, which might be linked to their illness.
Methodology
The study measured IL-6 levels in serum and synovial fluids from Behcet's disease patients, rheumatoid arthritis patients, and healthy controls, and assessed IL-6 production by PBMC and alveolar macrophages.
Limitations
The study did not explore the long-term effects of IL-6 levels or the impact of treatments on IL-6 production.
Participant Demographics
30 patients with Behcet's disease (28 men, 2 women) with a mean age of 34 years, compared to 10 rheumatoid arthritis patients and 20 healthy controls.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website